64 research outputs found
The Al-Rich Part of the Fe-Al Phase Diagram
The Al-rich part of the Fe-Al phase diagram between 50 and 80 at.% Al including the complex intermetallic phases FeAl (ε), FeAl, FeAl, and Fe4Al was re-investigated in detail. A series of 19 alloys was produced and heat-treated at temperatures in the range from 600 to 1100 °C for up to 5000 h. The obtained data were further complemented by results from a number of diffusion couples, which helped to determine the homogeneity ranges of the phases FeAl, FeAl, and FeAl. All microstructures were inspected by scanning electron microscopy (SEM), and chemical compositions of the equilibrium phases as well as of the alloys were obtained by electron probe microanalysis (EPMA). Crystal structures and the variation of the lattice parameters were studied by x-ray diffraction (XRD) and differential thermal analysis (DTA) was applied to measure all types of transition temperatures. From these results, a revised version of the Al-rich part of the phase diagram was constructed
Antimicrobial protein and Peptide concentrations and activity in human breast milk consumed by preterm infants at risk of late-onset neonatal sepsis
Objective: We investigated the levels and antimicrobial activity of antimicrobial proteins and peptides (AMPs) in breast milk consumed by preterm infants, and whether deficiencies of these factors were associated with late-onset neonatal sepsis (LOS), a bacterial infection that frequently occurs in preterm infants in the neonatal period. Study design: Breast milk from mothers of preterm infants (≤32 weeks gestation) was collected on days 7 (n = 88) and 21 (n = 77) postpartum. Concentrations of lactoferrin, LL-37, beta-defensins 1 and 2, and alpha-defensin 5 were measured by enzyme-linked immunosorbent assay. The antimicrobial activity of breast milk samples against Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, and Streptococcus agalactiae was compared to the activity of infant formula, alone or supplemented with physiological levels of AMPs. Samples of breast milk fed to infants with and without subsequent LOS were compared for levels of AMPs and inhibition of bacterial growth. Results: Levels of most AMPs and antibacterial activity in preterm breast milk were higher at day 7 than at day 21. Lactoferrin was the only AMP that limited pathogen growth >50% when added to formula at a concentration equivalent to that present in breast milk. Levels of AMPs were similar in the breast milk fed to infants with and without LOS, however, infants who developed LOS consumed significantly less breast milk and lower doses of milk AMPs than those who were free from LOS. Conclusions: The concentrations of lactoferrin and defensins in preterm breast milk have antimicrobial activity against common neonatal pathogens
Non-cationic proteins are associated with HIV neutralizing activity in genital secretions of female sex workers.
CAPRISA, 2015.Abstract available in pdf
Cathelicidin and its role in defence against bacterial infections of epithelial cells
Cathelicidins are antimicrobial peptides (AMPs) that were first discovered to have
microbicidal properties but more recently to be multifunctional immunomodulators and thus
important in influencing host defence against infectious disease. Whilst roles in various
organs have been demonstrated, their expression patterns in health and disease in other
organs are less clear and their key immunomodulatory functions remain undefined,
particularly with regard to the balance of immunomodulatory properties and microbicidal
activity in their ability to promote defence against infection.
I therefore set out to describe LL-37 expression (human cathelicidin) in the female
reproductive tract (across the menstrual cycle) and in the lung (during specific lung diseases),
to define the effects on the function of airway epithelial cells during bacterial infection and to
evaluate the key in vivo roles of endogenous cathelicidin (using a knockout mouse model) as
well as the effect of therapeutic administration of LL-37 in a pulmonary Pseudomonas
aeruginosa infection model.
I demonstrated that cathelicidin protein and transcription shows a cyclical pattern of
expression in female reproductive tissues which is maintained at high levels in decidua. LL-
37 protein was also detected in hTERT endometrial epithelial cells but despite the suggestion
that cathelicidin may be regulated by steroid hormones there was no direct effect of
progesterone on transcription. LL-37 is barely detected in healthy airways however is well
known to increase during infection or inflammation. I observed that sputum from patients
with bronchiectasis showed a correlation between the level of LL-37, TNF, MPO and chronic
colonisation of Pseudomonas aeruginosa. Patients with lung cancer expressed much less LL-
37 than the bronchiectasis patients but there was a trend towards increased production postsurgery
compared to pre-surgery.
LL-37 was previously shown by our lab to selectively promote BAX and caspase-dependant
death of infected epithelial cells. I went on to show that this appears to be a partially caspase-
1 dependent mechanism and that human bronchial epithelial (HBE) cells and A549 cell lines
both express several of the components required to form inflammasomes, a caspase-1
dependant form of inflammatory cell death.
Finally, I showed using murine models that cathelicidin enhances bacterial clearance during
pulmonary infection in vivo, a response which is defective in mice lacking endogenous
cathelicidin and that administration of exogenous, synthetic LL-37 at the time of infection
can promote an early protective neutrophil influx in the absence of endogenous cathelicidin
production
Cationic Host Defence Peptides:Potential as Antiviral Therapeutics
There is a pressing need to develop new antiviral treatments; of the 60 drugs currently available, half are aimed at HIV-1 and the remainder target only a further six viruses. This demand has led to the emergence of possible peptide therapies, with 15 currently in clinical trials. Advancements in understanding the antiviral potential of naturally occurring host defence peptides highlights the potential of a whole new class of molecules to be considered as antiviral therapeutics. Cationic host defence peptides, such as defensins and cathelicidins, are important components of innate immunity with antimicrobial and immunomodulatory capabilities. In recent years they have also been shown to be natural, broad-spectrum antivirals against both enveloped and non-enveloped viruses, including HIV-1, influenza virus, respiratory syncytial virus and herpes simplex virus. Here we review the antiviral properties of several families of these host peptides and their potential to inform the design of novel therapeutics
- …